Results 221 to 230 of about 3,800,975 (380)

The thrifty phenotype hypothesis.

open access: yesBritish Medical Bulletin, 2001
Nicholas Hales   +2 more
semanticscholar   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

PhenoFit: a framework for determining computable phenotyping algorithm fitness for purpose and reuse. [PDF]

open access: yesJ Am Med Inform Assoc
Wiley LK   +11 more
europepmc   +1 more source

Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study

open access: bronze, 2021
L. Legrand   +9 more
openalex   +2 more sources

CpG island methylator phenotype in colorectal cancer.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1999
M. Toyota   +5 more
semanticscholar   +1 more source

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

open access: yesMolecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek   +2 more
wiley   +1 more source

Editorial: Difficult and Severe Asthma in Children

open access: yesFrontiers in Pediatrics, 2019
Andrew Bush   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy